Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-05, Stock:JNJ, The news for the past five days is as follows:
2019-08-28: NEWS1: J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals?.NEWS2: J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals?.NEWS3: Johnson and Johnson Opioid Lawsuit and More Doom and Gloom.NEWS4: Johnson and Johnson Opioid Lawsuit and More Doom and Gloom.NEWS5: Dow Rises as Oil, Retail Tailwinds Help Stocks.NEWS6: Dow Rises as Oil, Retail Tailwinds Help Stocks.NEWS7: US Stocks Edge Higher Wednesday.NEWS8: Market Close Report: NASDAQ Composite index closes at 7,856.88 up 29.93 points.NEWS9: Market Close Report: NASDAQ Composite index closes at 7,856.88 up 29.93 points.NEWS10: Trump Wants the VA to Get as Much of This Drug as It Can.NEWS11: Trump Wants the VA to Get as Much of This Drug as It Can.NEWS12: Notable Wednesday Option Activity: JNJ, GILD, GLNG.NEWS13: Notable Wednesday Option Activity: JNJ, GILD, GLNG.NEWS14: What Purdue's Rumored Deal Means For Other Opioid-Tied Pharmas.NEWS15: J&J (JNJ) Loses Landmark Opioid Case: What's Next for Pharmaceuticals?.NEWS16: Johnson and Johnson Opioid Lawsuit and More Doom and Gloom.NEWS17: Trump Wants the VA to Get as Much of This Drug as It Can.NEWS18: Purdue Pharma offers $10-12B to settle opioid claims: RPT.NEWS19: Johnson & Johnson International Fin Svc Co -- Moody's affirms J&J at Aaa; revises outlook to negative.NEWS20: Microsoft, Visa share losses contribute to Dow's 65-point fall.NEWS21: Health Care Sector Update for 08/28/2019: PAHC, LCI, SNGX, JNJ, PFE, ABT, MRK, AMGN.NEWS22: Health Care Sector Update for 08/28/2019: PAHC, LCI, SNGX, JNJ, PFE, ABT, MRK, AMGN.NEWS23: Analysts view Johnson & Johnson’s $572 million fine as a win.NEWS24: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 29, 2019.NEWS25: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 29, 2019.NEWS26: Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates.NEWS27: We cannot win the war on drugs by obsessing over supply.NEWS28: Podcast: An August Climb for Treasuries.NEWS29: Here's How Rising Litigation Charges Are Impacting Johnson & Johnson’s Earnings.NEWS30: Here's How Rising Litigation Charges Are Impacting Johnson & Johnson’s Earnings.NEWS31: Opioids Threaten to Mess Up Europe, Too.NEWS32: 5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ.NEWS33: 5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ.NEWS34: Dow Jones Today: Not Much Activity, But That’s OK.NEWS35: Dow Jones Today: Not Much Activity, But That’s OK.
2019-08-29: NEWS1: Dow Grabs Another Big Win.NEWS2: Dow Grabs Another Big Win.NEWS3: Citi Turns Bullish On Jabil, Says Customer Risk Concentration 'Played Out'.NEWS4: Health Care Sector Update for 08/29/2019: LCI, JNJ, PFE, ABT, MRK, AMGN, SOLY, ESPR, CANF.NEWS5: Health Care Sector Update for 08/29/2019: LCI, JNJ, PFE, ABT, MRK, AMGN, SOLY, ESPR, CANF.NEWS6: Johnson & Johnson to Participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference.NEWS7: Why This Newly Profitable Biotech Stock Is Flirting With A Breakout.NEWS8: Papa John&apos;s Is Ready for Its Turnaround.NEWS9: Geron (GERN) Stock Rises 40% in 2019 So Far: Here's Why.NEWS10: Geron (GERN) Stock Rises 40% in 2019 So Far: Here's Why.NEWS11: Dow Movers: KO, INTC.NEWS12: Dow Movers: KO, INTC.NEWS13: Time Is Running Out for Johnson & Johnson Bulls.NEWS14: Geron (GERN) Stock Rises 40% in 2019 So Far: Here's Why.NEWS15: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.NEWS16: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.NEWS17: Opioid Crisis: Is Cannabis Legalization a Good Idea?.NEWS18: Health Care Sector Update for 08/29/2019: CANF, AZN, IBIO, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 08/29/2019: CANF, AZN, IBIO, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?.
2019-08-30: NEWS1: It’s Time to Short Johnson & Johnson Stock.NEWS2: It’s Time to Short Johnson & Johnson Stock.NEWS3: Dow Jones Rallies On China Trade Hopes; J&J Opioid Ruling, Best Buy, Burlington Stores, Ulta Beauty Earnings: Weekly Review.NEWS4: How the Johnson & Johnson Ruling Could Affect the Opioid Cases.NEWS5: It’s Time to Short Johnson & Johnson Stock.NEWS6: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS7: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS8: AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails.NEWS9: 3 Large-Cap Stocks to Sell in September.NEWS10: Purdue eyeing $12 billion settlement for 2,000 lawsuits.NEWS11: AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails.NEWS12: Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs.NEWS13: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS14: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS15: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 03, 2019.NEWS16: Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 03, 2019.NEWS17: Will Opioid Litigation Take its Toll on Pharma Companies?.NEWS18: Litigation alone cannot heal the opioid epidemic.NEWS19: A selection of the FT’s biggest stories and best reads every Friday.NEWS20: Papa John's Is Ready for Its Turnaround.NEWS21: Papa John's Is Ready for Its Turnaround.
2019-09-03: NEWS1: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS2: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS3: What the Johnson & Johnson Opioid Ruling Means for the Cannabis Industry.NEWS4: UPDATE 1-U.S. judge orders big drug companies to face opioid trial.NEWS5: iShares Russell 3000 ETF Experiences Big Inflow.NEWS6: iShares Russell 3000 ETF Experiences Big Inflow.NEWS7: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS8: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS9: Can Roche's Blockbuster Drug Herceptin's Sales Grow?.NEWS10: Can Roche's Blockbuster Drug Herceptin's Sales Grow?.NEWS11: Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 09/03/2019: CDTX, ENDP, MRK, ARDS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie.NEWS14: Bayer hires former J&J executive for more pharma deals.
2019-09-04: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS3: Health Care Sector Update for 09/04/2019: OPGN, PBYI, CODX, JNJ, PFE, ABT, MRK, AMGN.NEWS4: Forget Coca-Cola: Here Are 2 Better Dividend Stocks.

Answer: Decrease